Work

Supplementary Figure S3 from Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S3: Short-term and neo-adjuvant androgen deprivation therapy (ADT) has not exhibited direct effects on CCND1, CDKN2A, or RB1 in past gene expression studies of prostatic adenocarcinomas.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362399393
Cites:
Cited by:
Related to: 10